Green synthesized silver nanoparticles using Rhazya stricta extract for delivery of HDAC inhibitor panobinostat in MDA-MB-231 breast cancer cell line

Document Type : Research Paper


1 Department of Biomedical Engineering and Sciences, School of Mechanical and Manufacturing Engineering (SMME), National University of Sciences and Technology (NUST), Islamabad 44000, Pakistan

2 Department of Chemical Engineering, School of Chemical and Materials Engineering National University of Sciences and Technology (NUST), Islamabad 44000, Pakistan

3 Department of Gynecology and Obstetrics, Shaikh Zayed Hospital, Lahore, Pakistan



Objective(s): Concerns regarding increased breast cancer cases worldwide have spurred interest in the discovery of novel approaches to overcome this deadly disease. Although several treatment strategies have been developed to treat breast cancer including chemotherapy, an efficient drug delivery system remains a challenge. Here, we study the drug distribution and boosting the efficiency of Panobinostat, a histone deacetylase inhibitor, by using silver nanoparticles as a controlled drug delivery system.
Materials and Methods: Green synthesis of silver nanoparticles, as nanocarriers for drug delivery was synthesized by using Rhazya stricta extract and loaded with the drug. These drug-loaded nanoparticles were characterized by UV-vis spectroscopy, XRD, FTIR, SEM, and EDX techniques. 
Results: The AgNPs had an average size of 20 nm and were stable over a period. The evaluation of drug encapsulation effectiveness and drug release capacity revealed 56% encapsulation efficiency and sustained drug release. The kinetics study of drug release showed the first-order reaction which means that drug concentration is proportional to drug release. The MTT assay showed that drug-loaded AgNPs had a potent and dose-dependent anticancer activity on the breast cancer cell lines (MDA-MB-231). 
Conclusion: As the successfully green synthesized Panobinostat-AgNPs were stable and exhibited increased in vitro anticancer activity compared with free Panobinostat, our data demonstrate that the combination of AgNPs with Panobinostat improves the drug’s long-term viability, effectiveness, and active targeting as a potential targeted therapeutic molecule for the treatment of cancer. To strengthen the utilization of this combination therapy in cancer therapy trials, further research is warranted in vivo.


1. Le TT, Andreadakis Z, Kumar A, Roman RG, Tollefsen S, Saville M, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020; 19(5):305-306.
2. Siegel RL,  Miller KD,  Fuchs HE,  Jemal A.  Cancer statistics, 2022. CA Cancer J Clin. 2022.
3. Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L. Current Challenges in Cancer Treatment. Clin Ther. 2016;38(7):1551-1566. 
4. Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature. 2019;575(7782):299-309.
5. Hassan S, Shehzad A, Khan SA, Miran W, Khan S, Lee YS. Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer Management. Biomedicines. 2022;10(8):2047.
5. Islam SU, Ahmed MB, Ahsan H, Islam M, Shehzad A, Sonn JK,  et al. An Update on the Role of Dietary Phytochemicals in Human Skin Cancer: New Insights into Molecular Mechanisms. Antioxidants (Basel). 2020;9(10):916.
6. Bai R, Chen N, Li L, Du N, Bai L,  Lv Z, et al. Mechanisms of Cancer Resistance to Immunotherapy. Front Oncol. 2020;10:1290.
7. Islam S.U, Ahmed MB, Lee SJ, Shehzad A, Sonn JK, Kwon OS, et al. PRP4 kinase induces actin rearrangement and epithelial-mesenchymal transition through modulation of the actin-binding protein cofilin. Exp Cell Res. 2018. 369(1):158-165.
8. Islam SU, Ul-Islam M, Ahsan H, Ahmed MB, Shehzad A, Atiya F, et al. Potential applications of bacterial cellulose and its composites for cancer treatment. Int J Biol Macromol. 2021;168:301-309. 
9. Azharuddin M , Zhu GH , Das D ,Ozgur E, Uzun L, Turner APF, et al. A repertoire of biomedical applications of noble metal nanoparticles. Chem Commun (Camb). 2019;55(49):6964-6996.
10. Islam SU, Ahmed MB, Islam MU, Shehzad A, Lee YS. Switching from Conventional to Nano-natural Phytochemicals to Prevent and Treat Cancers: Special Emphasis on Resveratrol. Curr Pharm Des. 2019;25(34):3620-3632.
11. Islam SU, Lee JH, Shehzad A, Ahn EM, Lee YM, Lee YS. Decursinol Angelate Inhibits LPS-Induced Macrophage Polarization through Modulation of the NFκB and MAPK Signaling Pathways. Molecules. 2018;23(8):1880. 
12.    Etter EL, Mei KC, Nguyen J. Delivering more for less: Nanosized, minimal-carrier and pharmacoactive drug delivery systems. Adv Drug Deliv Rev. 2021;179:113994. 
13.    Unsoy G, Gunduz U. Smart Drug Delivery Systems in Cancer Therapy. Curr Drug Targets. 2018;19(3):202-212. 
14.    Janjua KA, Shehzad A, Shahzad R, Islam SU, Islam MU. Nanocurcumin: A Double-Edged Sword for Microcancers. Curr Pharm Des. 2020;26(45):5783-5792.
15.    Kazmi Z, Zeeshan S, Khan A, Malik S, Shehzad A, Seo EK, et al. Anti-epileptic activity of daidzin in PTZ-induced mice model by targeting oxidative stress and BDNF/VEGF signaling. Neurotoxicology. 2020;79:150-163.
16.    Khan AU, Khan A, Khan A,  Shal B, Aziz A, Ahmed MN, et al. Inhibition of NF-κB signaling and HSP70/HSP90 proteins by newly synthesized hydrazide derivatives in arthritis model [retracted in: Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):3341]. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(7):1497-1519.
17.    Zhang XF, Liu ZG, Shen W, Gurunathan S. Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches. Int J Mol Sci. 2016;17(9):1534.
18.    Liu X, Chen JL, Yang WY, Qian YC, Pan JY, Zhu CN, et al. Biosynthesis of silver nanoparticles with antimicrobial and anticancer properties using two novel yeasts. Sci Rep. 2021;11(1):15795.
19.    Khan FA, Lammari N, Muhammad Siar AS, Alkhater KM, Asiri S, Akhtar S, et al. Quantum dots encapsulated with curcumin inhibit the growth of colon cancer, breast cancer and bacterial cells. Nanomedicine (Lond). 2020;15(10):969-980.
20.    Shehzad A, Qureshi M, Jabeen S, Ahmed R, Alabdalall AH, Aljafary MA, et al. Synthesis, characterization and antibacterial activity of silver nanoparticles using Rhazya stricta. PeerJ. 2018;6:e6086.
21.    Albeshri A, Baeshen NA, Bouback TA, Aljaddawi AA. A Review of Rhazya strictaDecne Phytochemistry, Bioactivities, Pharmacological Activities, Toxicity, and Folkloric Medicinal Uses. Plants (Basel). 2021;10(11):2508.
22.    Ali BH, Al-Qarawi AA, Bashir AK, Tanira MO. Phytochemistry, pharmacology and toxicity of Rhazya stricta decne: A review. Phytother Res. 2000;14(4):229-234.
23. Ullah, I. A review of phytochemistry, bioactivities and ethno medicinal uses of Rhazya stricta Decsne (Apocynaceae). Af J Microbiol Rese. 2012;6:1629-1641.
24. Gilani SA, Kikuchi A, Shinwari ZK, Khattak ZI, Watanabe KN. Phytochemical, pharmacological and ethnobotanical studies of Rhazya stricta Decne. Phytother Res. 2007;21(4):301-307.
25. Ravinayagam V, Shehzad A, Almohazey D, Almofty S, Jafary MA, AlhAMED N, et al., Decursin induces apoptosis by regulating AMP-activated protein kinase and Bax/Bcl-2 pathway in HepG2 cell line. European Journal of Integrative Medicine, 2018;24:17-22.
26. Shahzad R, Shehzad A, Bilal S, Lee IJ. Bacillus amyloliquefaciens RWL-1 as a New Potential Strain for Augmenting Biochemical and Nutritional Composition of Fermented Soybean. Molecules. 2020;25(10):2346.
27. Bawazeer S, Rauf A, Emran TB, Aljohani ASM, Alhumaydhi FA, Khan Z, et al., Biogenic synthesis of silver nanoparticles using rhazya stricta extracts and evaluation of its biological activities. Journal of Nanomaterials. 2022;2022.
28. Nadeem AY, Shehzad A, Islam SU, Al-Suhaimi EA, Lee YS. Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy. Vaccines (Basel). 2022;10(5):713.
29. Zhao C, Dong H, Xu Q, Zhang Y. Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present). Expert Opin Ther Pat. 2020;30(4):263-274. 
30. Chaudhuri S, Fowler MJ, Baker C, Stopka SA, Regaan MS, Sablaaatura L, et al. β-Cyclodextrin-poly (β-Amino Ester) Nanoparticles Are a Generalizable Strategy for High Loading and Sustained Release of HDAC Inhibitors. ACS Appl Mater Interfaces. 2021;13(18):20960-20973.
31. Shehzad, A., Curcumin potential and problems in pancreatic cancer. Pancreat Disorders Ther. 2021; 11: S6.
32. Shehzad A, Islam SU, Shahzad R, Khan S, Lee YS. Extracellular vesicles in cancer diagnostics and therapeutics. Pharmacol Ther. 2021;223:107806. 
33. Eleutherakis-Papaiakovou E, Kanellias N, Kastritis E, Gavriatopoulou M, Terpos E, Dimopoulos MA. Efficacy of Panobinostat for the Treatment of Multiple Myeloma. J Oncol. 2020;2020:7131802.
34. Sivaraj D, Green MM, Gasparetto C. Panobinostat for the management of multiple myeloma. Future Oncol. 2017;13(6):477-488.
35. Shehzad A, Ravinayagam V, AlRumaih H, Aljafary M, Almohazey D, Almofty S, et al. Application of Three-dimensional (3D) Tumor Cell Culture Systems and Mechanism of Drug Resistance. Curr Pharm Des. 2019;25(34):3599-3607. 
36. Shehzad A, Rehmat S, Ul-Islam S, Ahmaad R, Aljafary M, Alrushaid NA, et al. Lirioresinol B dimethyl ether inhibits NF-κB and COX-2 and activates IκBα expression in CCl4-induced hepatic fibrosis. BMC Complement Med Ther. 2020;20(1):49.
37. Shabestarian H, Tabrizi MH, Movehedi M, Neamati Ali, Sharifnia F. Green synthesis of Ag-NPs as a metal nanoparticle and ZnO-NPs as a metal oxide nanoparticle: Evaluation of the in vitrocytotoxicity, anti-oxidant, anti-angiogenic activities. Nanomed J. 2023;10(3):245-258.
38. Azimi F, Mahmoudi F, Mahmoudi F, Amini. MM. Synthesis of silver nanoparticles by Galega officinalis and its hypoglycemic effects in type 1 diabetic rats. Nanomed J. 2021;8(4):255-263.
39.    Campoy AHG, Jeronimo FM, Gutierrez RMP, Ramirez AM. Silver nanoparticles synthesized with a fraction from the bark of Eysenhardtia polystachya with high chalcone and dihydrochalcone content effectively inhibit oxidative stress in the zebrafish embryo model. Nanomed J. 2018; 5(3):152-162.
40.    Anandalakshmi K. Venugobal J, Ramasamy V. Characterization of silver nanoparticles by green synthesis method using Pedalium murex leaf extract and their antibacterial activity. Appl Nanosci 2016;6:399–408.
41. Rezazadeh NH, Buazar F, Matroodi S. Synergistic effects of combinatorial chitosan and polyphenol biomolecules on enhanced antibacterial activity of biofunctionalaized silver nanoparticles. Sci Rep. 2020;10(1):19615.
42.    Sadat Shandiz SA, Shafiee Ardestani M, Shahbazzadeh D, Assadi A, Cohan RA, Asgary V, et al. Novel imatinib-loaded silver nanoparticles for enhanced apoptosis of human breast cancer MCF-7 cells. Artif Cells Nanomed Biotechnol. 2017;45(6):1-10.
43. Tan JM, Karthivashan G, Gani SA, Fakurazi S, Hussein MZ. In vitro drug release characteristic and cytotoxic activity of silibinin-loaded single walled carbon nanotubes functionalized with biocompatible polymers. Chem Cent J. 2016;10:81.